Charles & Colvard, Ltd. manufactures, markets, and distributes moissanite jewels and finished jewelries worldwide. It operates through Online Channels, and Traditional segments. The company offers stud earrings, solitaire and three stone rings, pendants, and bracelets. It also provides colorless moissanite jewel with 27 cuts and in sizes ranging from .002 carats to 6.13 carats, under the brand name Forever One, as well as gemstones under the brand name Moissanite by Charles & Colvard. In addition, the company offers Exotics product line with 15.55 carats diamond equivalent weight. It sells its products through distributors, manufacturers, retailers, and designers; and at retail to end consumers through its e-commerce site, charlesandcolvard.com, as well as third-party online marketplaces, drop-ship, and e-commerce outlets. Charles & Colvard, Ltd. was founded in 1995 and is based in Morrisville, North Carolina.
IPO Year: 1997
Exchange: NASDAQ
Website: charlesandcolvard.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/3/2021 | $3.50 → $3.75 | Buy | Roth Capital |
NT 10-Q - CHARLES & COLVARD LTD (0001015155) (Filer)
8-K - CHARLES & COLVARD LTD (0001015155) (Filer)
10-K - CHARLES & COLVARD LTD (0001015155) (Filer)
8-K - CHARLES & COLVARD LTD (0001015155) (Filer)
8-K - CHARLES & COLVARD LTD (0001015155) (Filer)
NT 10-Q - CHARLES & COLVARD LTD (0001015155) (Filer)
8-K - CHARLES & COLVARD LTD (0001015155) (Filer)
8-K - CHARLES & COLVARD LTD (0001015155) (Filer)
8-K - CHARLES & COLVARD LTD (0001015155) (Filer)
8-K - CHARLES & COLVARD LTD (0001015155) (Filer)
ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition. Mr. Haverhals' retirement, following a distinguished career of over 30 years in the medical device and pharmaceutical industries, reflects his desire to spend more ti
RESEARCH TRIANGLE PARK, N.C., June 28, 2021 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created moissanite and lab grown diamonds, announced today the Company's addition to the Russell Microcap® Index, effective after the US market opens on June 28, 2021, as a part of the Russell indexes annual reconstitution. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines
SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)
SC 13G/A - CHARLES & COLVARD LTD (0001015155) (Subject)
SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)
SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)
SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)
SC 13D - CHARLES & COLVARD LTD (0001015155) (Subject)
SC 13G/A - CHARLES & COLVARD LTD (0001015155) (Subject)
SC 13G/A - CHARLES & COLVARD LTD (0001015155) (Subject)
SC 13G - CHARLES & COLVARD LTD (0001015155) (Subject)
SC 13G/A - CHARLES & COLVARD LTD (0001015155) (Subject)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
Roth Capital reiterated coverage of Charles & Colvard with a rating of Buy and set a new price target of $3.75 from $3.50 previously
RESEARCH TRIANGLE PARK, N.C., April 22, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company"), announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC ("Nasdaq"), informing the Company that Nasdaq determined to suspend trading and delist the Company's common stock (the "Common Stock") from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a car
RESEARCH TRIANGLE PARK, N.C., March 3, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepted the Company's plan to regain compliance with the Listing Rule and granted the Company until April 14, 2025 to file its Annual Report on For
RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on December 5, 2024, it received an interim award in its confidential arbitration with Wolfspeed, Inc. Importantly, the award rejected Wolfspeed's claims to expectation damages of approximately $22.8 million, limiting the Company's damages to just $3.3 million representing approximately $1.3 million for inventory previously purchased and approximately $2.0 million of consigned inventory in the Company's possession, that will now be recorded on the Company's balance sheet as of June 30, 2024 - along with interest, arbitration and limite
RESEARCH TRIANGLE PARK, N.C., Nov. 27, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on November 21, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic reports (the "Listing Rule"), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024 (the "Form 10-Q"), and because the Company remains delinquent in filing its Form 10-K for the fiscal year ended June
ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition. Mr. Haverhals' retirement, following a distinguished career of over 30 years in the medical device and pharmaceutical industries, reflects his desire to spend more ti
RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on October 18, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic reports (the "Listing Rule"), as a result of not having timely filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (the "Form 10-K"), with the Securities and Exchange Commission (the "SEC"). The Form 10-K was due on September 30, 2024. The Com
Notes that Purported Nomination of Director Candidates by a Riverstyx Principal Is Invalid and that the Nominations Will Not be Recognized RESEARCH TRIANGLE PARK, N.C., Oct. 7, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today commented on a letter sent to the Company's shareholders and released publicly by Riverstyx Capital Management, LLC ("Riverstyx"). The Company provided the following statement in response: On August 27, Charles & Colvard received a purported notice (the "Notice") from Ben Franklin, a principal of Riv
RESEARCH TRIANGLE PARK, N.C., June 6, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, announced today that it has regained compliance with Nasdaq's minimum bid price continued listing requirement. A letter from Nasdaq Listing Qualifications Department noted that as of May 31, 2024, the minimum bid price of the Company's common stock was $1.00 per share or greater for the last 10 consecutive business/trading days. As a result, the Company has now regained compliance with Listing Rule 5550(a)(2) and the matter is now closed.
RESEARCH TRIANGLE PARK, N.C., May 23, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, is pleased to announce an exclusive strategic alliance with the International Gemological Institute (IGI), introducing comprehensive grading reports for moissanite gemstones and jewelry. "Not all moissanite is created equal," says Don O'Connell, President and CEO of Charles & Colvard. "The new collaboration with IGI emphasizes our commitment to maintaining brand integr
RESEARCH TRIANGLE PARK, N.C., May 15, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, announced today that the Company's Board of Directors has approved a one-for-ten (1:10) reverse split of the Company's common stock, no par value per share (the "Reverse Stock Split"), to be effective as of 12:01 a.m. Eastern Time on May 17, 2024 (the "Effective Date"). The Reverse Stock Split is intended to bring the Company into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing. The Company expects its common stock to begin trading on a sp
Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., May 2, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal 2024"). Management Commentary "We remain committed to growth despite a challenging third quarter. We believe our strategic initiatives, continued investments in innovative technology, and dedica
RESEARCH TRIANGLE PARK, N.C., April 23, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, will host an investor conference call and webcast presentation to discuss its financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal Year 2024") at 4:30 p.m. ET on Thursday, May 2, 2024. The Company will release its financial results after market close on the same day. Third Quarter Fiscal Year 2024 Conference Call DetailsDate and Time: T
Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the second quarter ended December 31, 2023 ("Second Quarter Fiscal 2024"). Management Commentary "We acknowledge the recent industry shift has presented us with numerous challenges and has significantly impacted our earnings. However, we do not believe t
RESEARCH TRIANGLE PARK, N.C., Feb. 6, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, will host an investor conference call and webcast presentation to discuss its financial results for the second quarter ended December 31, 2023 ("Second Quarter Fiscal Year 2024") at 4:30 p.m. ET on Tuesday, February 13, 2024. The Company will release its financial results after market close on the same day. Second Quarter Fiscal Year 2024 Conference Call Details Date a
Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., Oct. 12, 2023 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the fourth quarter ended June 30, 2023 ("Fourth Quarter Fiscal 2023"). Management Commentary "While the challenging macroeconomic backdrop and weakened consumer outlook created significant headwinds on the jewelry and gemstone industry, and on the Compan
RESEARCH TRIANGLE PARK, N.C., Oct. 10, 2023 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, will host an investor conference call and webcast presentation to discuss its financial results for the quarter and fiscal year ended June 30, 2023 ("Fourth Quarter Fiscal Year 2023") at 4:30 p.m. ET on Thursday, October 12, 2023. The Company will release its financial results after the market close on the same day. Fourth Quarter and Fiscal Year 2023 Conference Call
Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., May 4, 2023 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created Made, Not MinedTM gemstones, reported financial results for the third quarter ended March 31, 2023 ("Third Quarter Fiscal 2023"). Management Commentary "We remain focused on capitalizing on the changing behaviors and dynamics in the fine jewelry market, and we continued to make strategic investments in our direct
RESEARCH TRIANGLE PARK, N.C., April 20, 2023 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, will host an investor conference call and webcast presentation to discuss its financial results for the quarter ended March 31, 2023 ("Third Quarter Fiscal Year 2023") at 4:30 p.m. ET on Thursday, May 4, 2023. The Company will release its financial results after the market close on the same day. Third Quarter Fiscal Year 2023 Conference Call Details Date and Time: Th
Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET $10.4 million in net sales for the quarter ended December 31, 2022.Generated positive cash flow from operations of $600,000 during the quarter ended December 31, 2022.$17.0 million total cash as of December 31, 2022.Online Channels sales were 76% of revenues in the second quarter, up from 68% in the prior year's second quarter and 62% in the second quarter of fiscal year 2021.Finished jewelry represented 81% of net sales, up from 77% in the prior year's second quarter.19% increase in lab grown diamond sales during Q2 of 2023 versus the comparable year ago period and up 603% YTD 2023 versus YTD 2021 levels.Open
RESEARCH TRIANGLE PARK, N.C., Jan. 19, 2023 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created Made, Not Mined™ gemstones, will host an investor conference call and webcast presentation to discuss its financial results for the quarter ended December 31, 2022 ("Second Quarter Fiscal Year 2023") at 4:30 p.m. ET on Thursday, February 2, 2023. The Company will release its financial results after the market close on the same day. Second Quarter Fiscal Year 2023 Conference Call DetailsDate and
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)
4 - CHARLES & COLVARD LTD (0001015155) (Issuer)